NEWS
HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules
HCW Biologics (NASDAQ: HCWB) has announced a $6.9 million registered direct offering and concurrent private placement priced above market. The company will issue 6,717,000 shares of common stock (or pre-funded warrants) at a combined effective price of $1.03 per share. Additionally, unregistered warrants to purchase up to 6,717,000 shares will be issued with an exercise price of $1.03, exercisable immediately with a five-year expiration. The offering, managed by Maxim Group as sole placement agent, is expected to close around November 20, 2024.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
2537Followers
107Following
27KVisitors
Follow
Lnova :
Lnova : thank you for posting!!
Jaguar8 OP Lnova : I expected this since they only have 500K cash
Lnova Jaguar8 OP : seriously?
damn lol
Jaguar8 OP Lnova : Yup
KY-To the moon : good or bad ?
Jaguar8 OP KY-To the moon : It’s dilution of shares
KY-To the moon Jaguar8 OP : so mean stock will go down? ouch
Jaguar8 OP KY-To the moon : Still depends of market sentiment but it is dilution
Jaguar8 OP Lnova : See even with dilution news it pumps hahaha